The systemic immune-inflammation index is superior to predicting clinical remission and relapse for ulcerative colitis patients treated with vedolizumab - Yan, Jing; Wu, Jun; Wang, Rongkun; Meng, Pin; Liu, Ailing; Xu, Yonghong (Frontiers in Medicine, 2025)